Table 2.

Disease-Based Documents

Section	Writer
Executive summary	Lead author(s)
Public health relevance	Staff
Requirements for diagnosis, treatment, and monitoring	Lead author(s)
Overview of regimens	Lead author(s)
Review of benefits and harms (including systematic reviews)	Lead author(s) and staff
Recommendations	Lead author(s)
Additions proposed for section 8.2 of EML	Lead author(s)
Supplementary documents
Medicine prices from MSH price indicator guide (2014)	Staff
Costing scenarios	Staff
Regulatory information for recommended medicines	Staff
Patent status for recommended medicines	Staff
Granulocyte colony-stimulating factor	Lead author(s) and staff

Abbreviations: EML, Model List of Essential Medicines; MSH, Management Sciences for Health.